Keywords
Last Name
Institution

David G. Hoel

Title
InstitutionMedical University of South Carolina
DepartmentPublic Health Sciences
Address
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Hoel DG, de Gruijl FR. Sun Exposure Public Health Directives. Int J Environ Res Public Health. 2018 12 10; 15(12). PMID: 30544646.
      View in: PubMed
    2. Hoel DG. Quantitative Risk Assessment in the 1970s: A Personal Remembrance. Dose Response. 2018 Oct-Dec; 16(4):1559325818803230. PMID: 30302069.
      View in: PubMed
    3. Hoel DG. Nuclear epidemiologic studies and the estimation of DREF. Int J Radiat Biol. 2018 04; 94(4):307-314. PMID: 29400635.
      View in: PubMed
    4. Dauer LT, Ainsbury EA, Dynlacht J, Hoel D, Klein BEK, Mayer D, Prescott CR, Thornton RH, Vano E, Woloschak GE, Flannery CM, Goldstein LE, Hamada N, Tran PK, Grissom MP, Blakely EA. Guidance on radiation dose limits for the lens of the eye: overview of the recommendations in NCRP Commentary No. 26. Int J Radiat Biol. 2017 10; 93(10):1015-1023. PMID: 28346025.
      View in: PubMed
    5. Hoel DG, Carnes BA. Cardiovascular effects of fission neutron or 60Co ? exposure in the B6CF1 mouse. Int J Radiat Biol. 2017 06; 93(6):563-568. PMID: 28112567.
      View in: PubMed
    6. Hoel DG. Commercial tanning salons and melanoma risk. Dermatoendocrinol. 2017; 9(1):e1270485. PMID: 28405266.
      View in: PubMed
    7. Hoel DG, Berwick M, de Gruijl FR, Holick MF. The risks and benefits of sun exposure 2016. Dermatoendocrinol. 2016 Jan-Dec; 8(1):e1248325. PMID: 27942349.
      View in: PubMed
    8. Brooks AL, Hoel DG, Preston RJ. The role of dose rate in radiation cancer risk: evaluating the effect of dose rate at the molecular, cellular and tissue levels using key events in critical pathways following exposure to low LET radiation. Int J Radiat Biol. 2016 08; 92(8):405-26. PMID: 27266588.
      View in: PubMed
    9. Soffritti M, Tibaldi E, Padovani M, Hoel DG, Giuliani L, Bua L, Lauriola M, Falcioni L, Manservigi M, Manservisi F, Belpoggi F. Synergism between sinusoidal-50?Hz magnetic field and formaldehyde in triggering carcinogenic effects in male Sprague-Dawley rats. Am J Ind Med. 2016 07; 59(7):509-21. PMID: 27219869.
      View in: PubMed
    10. Soffritti M, Tibaldi E, Padovani M, Hoel DG, Giuliani L, Bua L, Lauriola M, Falcioni L, Manservigi M, Manservisi F, Panzacchi S, Belpoggi F. Life-span exposure to sinusoidal-50?Hz magnetic field and acute low-dose ? radiation induce carcinogenic effects in Sprague-Dawley rats. Int J Radiat Biol. 2016; 92(4):202-14. PMID: 26894944.
      View in: PubMed
    11. Dauer LT, Ainsbury EA, Dynlacht J, Hoel D, Klein BE, Mayer D, Prescott CR, Thornton RH, Vano E, Woloschak GE, Flannery CM, Goldstein LE, Hamada N, Tran PK, Grissom MP, Blakely EA. Status of NCRP Scientific Committee 1-23 Commentary on Guidance on Radiation Dose Limits for the Lens of the Eye. Health Phys. 2016 Feb; 110(2):182-4. PMID: 26717175.
      View in: PubMed
    12. Hoel DG. Comments on the DDREF estimate of the BEIR VII Committee. Health Phys. 2015 Mar; 108(3):351-6. PMID: 25627947.
      View in: PubMed
    13. Moolgavkar SH, Anderson EL, Chang ET, Lau EC, Turnham P, Hoel DG. A review and critique of U.S. EPA's risk assessments for asbestos. Crit Rev Toxicol. 2014 Jul; 44(6):499-522. PMID: 24806876.
      View in: PubMed
    14. Priest ND, Hoel D, Uralbekov B, Baizakova DO, Burkitbayev M. Childhood exposures to Rn-222 and background gamma radiation in the uranium provinces of south Kazakhstan and northern Kyrgyzstan. J Environ Radioact. 2013 Sep; 123:99-103. PMID: 22727647.
      View in: PubMed
    15. Priest ND, Hoel D. Determining the relative toxicity and RBE of internal emitters in animals. Health Phys. 2010 Sep; 99(3):367-70. PMID: 20699699.
      View in: PubMed
    16. Dauer LT, Brooks AL, Hoel DG, Morgan WF, Stram D, Tran P. Review and evaluation of updated research on the health effects associated with low-dose ionising radiation. Radiat Prot Dosimetry. 2010 Jul; 140(2):103-36. PMID: 20413418.
      View in: PubMed
    17. Priest ND, Hoel DG, Brooks PN. Relative toxicity of (45)Ca beta-particles and (242)Cm alpha-particles following their intravenous injection into mice as radiolabelled FAP. Int J Radiat Biol. 2010 Apr; 86(4):300-20. PMID: 20353340.
      View in: PubMed
    18. Svendsen ER, Kolpakov IE, Stepanova YI, Vdovenko VY, Naboka MV, Mousseau TA, Mohr LC, Hoel DG, Karmaus WJ. 137Cesium exposure and spirometry measures in Ukrainian children affected by the Chernobyl nuclear incident. Environ Health Perspect. 2010 May; 118(5):720-5. PMID: 20100677.
      View in: PubMed
    19. Wilson DA, Mohr LC, Frey GD, Lackland D, Hoel DG. Lung, liver and bone cancer mortality after plutonium exposure in beagle dogs and nuclear workers. Health Phys. 2010 Jan; 98(1):42-52. PMID: 19959950.
      View in: PubMed
    20. Gebregziabher M, Hoel D. Applications of the Poly-K Statistical Test to Life-Time Cancer Bioassay Studies. Hum Ecol Risk Assess. 2009 Sep 01; 15(5):858-875. PMID: 20508734.
      View in: PubMed
    21. Wilson DA, Diel JH, Hoel DG. Lung fibrosis and lung cancer incidence in beagle dogs that inhaled 238PuO2 or 239PuO2. Health Phys. 2009 Apr; 96(4):493-503. PMID: 19280755.
      View in: PubMed
    22. Jollow DJ, Bruckner JV, McMillan DC, Fisher JW, Hoel DG, Mohr LC. Trichloroethylene risk assessment: a review and commentary. Crit Rev Toxicol. 2009; 39(9):782-97. PMID: 19852561.
      View in: PubMed
    23. McGreevy KM, Lipsitz SR, Linder JA, Rimm E, Hoel DG. Using median regression to obtain adjusted estimates of central tendency for skewed laboratory and epidemiologic data. Clin Chem. 2009 Jan; 55(1):165-9. PMID: 19028825.
      View in: PubMed
    24. Little MP, Hoel DG, Molitor J, Boice JD, Wakeford R, Muirhead CR. New models for evaluation of radiation-induced lifetime cancer risk and its uncertainty employed in the UNSCEAR 2006 report. Radiat Res. 2008 Jun; 169(6):660-76. PMID: 18494541.
      View in: PubMed
    25. Baker PJ, Hoel DG. Meta-analysis of standardized incidence and mortality rates of childhood leukaemia in proximity to nuclear facilities. Eur J Cancer Care (Engl). 2007 Jul; 16(4):355-63. PMID: 17587361.
      View in: PubMed
    26. Adelman AS, Groves FD, O'Rourke K, Sinha D, Hulsey TC, Lawson AB, Wartenberg D, Hoel DG. Residential mobility and risk of childhood acute lymphoblastic leukaemia: an ecological study. Br J Cancer. 2007 Jul 02; 97(1):140-4. PMID: 17533404.
      View in: PubMed
    27. Reiss R, Anderson EL, Cross CE, Hidy G, Hoel D, McClellan R, Moolgavkar S. Evidence of health impacts of sulfate-and nitrate-containing particles in ambient air. Inhal Toxicol. 2007 May; 19(5):419-49. PMID: 17365047.
      View in: PubMed
    28. McGreevy KM, Hoel BD, Lipsitz SR, Hoel DG. Impact of nutrients on insulin-like growth factor-I, insulin-like growth factor binding protein-3 and their ratio in African American and white males. Public Health Nutr. 2007 Jan; 10(1):97-105. PMID: 17212848.
      View in: PubMed
    29. Priest ND, Hoel DG, Brooks PN. Relative toxicity of chronic irradiation by 45Ca beta particles and 242Cm alpha particles with respect to the production of lung tumors in CBA/Ca mice. Radiat Res. 2006 Nov; 166(5):782-93. PMID: 17067209.
      View in: PubMed
    30. Hoel DG. Ionizing radiation and cardiovascular disease. Ann N Y Acad Sci. 2006 Sep; 1076:309-17. PMID: 17119211.
      View in: PubMed
    31. Bronley-DeLancey A, McMillan DC, McMillan JM, Jollow DJ, Mohr LC, Hoel DG. Application of cryopreserved human hepatocytes in trichloroethylene risk assessment: relative disposition of chloral hydrate to trichloroacetate and trichloroethanol. Environ Health Perspect. 2006 Aug; 114(8):1237-42. PMID: 16882532.
      View in: PubMed
    32. McGreevy K, Rodgers K, Lipsitz S, Bissada N, Hoel D. Impact of race and baseline PSA on longitudinal PSA. Int J Cancer. 2006 Apr 01; 118(7):1773-6. PMID: 16231314.
      View in: PubMed
    33. Makie T, Adcock D, Lackland DT, Hoel DG. Pulmonary abnormalities associated with occupational exposures at the Savannah River Site. Am J Ind Med. 2005 Nov; 48(5):365-72. PMID: 16254950.
      View in: PubMed
    34. McGreevy K, Hoel B, Lipsitz S, Bissada N, Hoel D. Racial and anthropometric differences in plasma levels of insulin-like growth factor I and insulin-like growth factor binding protein-3. Urology. 2005 Sep; 66(3):587-92. PMID: 16140083.
      View in: PubMed
    35. Starr TB, Goodman JI, Hoel DG. Uses of benchmark dose methodology in quantitative risk assessment. Regul Toxicol Pharmacol. 2005 Jun; 42(1):1-2. PMID: 15896437.
      View in: PubMed
    36. Heath CW, Bond PD, Hoel DG, Meinhold CB. Residential radon exposure and lung cancer risk: commentary on Cohen's county-based study. Health Phys. 2004 Dec; 87(6):647-55; discussion 656-8. PMID: 15545771.
      View in: PubMed
    37. Baker GS, Hoel DG. Corrections in the atomic bomb data to examine low dose risk. Health Phys. 2003 Dec; 85(6):709-20. PMID: 14626322.
      View in: PubMed
    38. Creasman WT, Hoel D, Disaia PJ. WHI: Now that the dust has settled: a commentary. Am J Obstet Gynecol. 2003 Sep; 189(3):621-6. PMID: 14526278.
      View in: PubMed
    39. Nicholas JS, Butler GC, Davis S, Bryant E, Hoel DG, Mohr LC. Stable chromosome aberrations and ionizing radiation in airline pilots. Aviat Space Environ Med. 2003 Sep; 74(9):953-6. PMID: 14503673.
      View in: PubMed
    40. Carnes BA, Grahn D, Hoel D. Mortality of atomic bomb survivors predicted from laboratory animals. Radiat Res. 2003 Aug; 160(2):159-67. PMID: 12859226.
      View in: PubMed
    41. McGreevy KM, Baron LF, Hoel DG. Clinical breast examination practices among women undergoing screening mammography. Radiology. 2002 Aug; 224(2):555-9. PMID: 12147856.
      View in: PubMed
    42. Schubauer-Berigan MK, Frey GD, Baron L, Hoel DG. Mammography dose in relation to body mass index, race, and menopausal status. Radiat Prot Dosimetry. 2002; 98(4):425-32. PMID: 12120670.
      View in: PubMed
    43. Schubauer-Berigan MK, Baron L, Frey GD, Hoel DG. Breast dose variability in a bi-racial population undergoing screening mammography. Radiat Prot Dosimetry. 2002; 98(4):417-24. PMID: 12120669.
      View in: PubMed
    44. Nicholas JS, Butler GC, Lackland DT, Tessier GS, Mohr LC, Hoel DG. Health among commercial airline pilots. Aviat Space Environ Med. 2001 Sep; 72(9):821-6. PMID: 11565817.
      View in: PubMed
    45. Nicholas JS, Butler GC, Lackland DT, Hood WC, Hoel DG, Mohr LC. Flight deck magnetic fields in commercial aircraft. Am J Ind Med. 2000 Nov; 38(5):548-54. PMID: 11025496.
      View in: PubMed
    46. Radivoyevitch T, Hoel DG. Biologically-based risk estimation for radiation-induced chronic myeloid leukemia. Radiat Environ Biophys. 2000 Sep; 39(3):153-9. PMID: 11095145.
      View in: PubMed
    47. Radivoyevitch T, Hoel DG. Modeling the low-LET dose-response of BCR-ABL formation: predicting stem cell numbers from A-bomb data. Math Biosci. 1999 Nov-Dec; 162(1-2):85-101. PMID: 10616282.
      View in: PubMed
    48. Grosche B, Lackland D, Mohr L, Dunbar J, Nicholas J, Burkart W, Hoel D. Leukaemia in the vicinity of two tritium-releasing nuclear facilities: a comparison of the Kruemmel Site, Germany, and the Savannah River Site, South Carolina, USA. J Radiol Prot. 1999 Sep; 19(3):243-52. PMID: 10503702.
      View in: PubMed
    49. Dinse GE, Umbach DM, Sasco AJ, Hoel DG, Davis DL. Unexplained increases in cancer incidence in the United States from 1975 to 1994: possible sentinel health indicators? Annu Rev Public Health. 1999; 20:173-209. PMID: 10352856.
      View in: PubMed
    50. Nicholas JS, Lackland DT, Butler GC, Mohr LC, Dunbar JB, Kaune WT, Grosche B, Hoel DG. Cosmic radiation and magnetic field exposure to airline flight crews. Am J Ind Med. 1998 Dec; 34(6):574-80. PMID: 9816415.
      View in: PubMed
    51. Nicholas JS, Lackland DT, Dosemeci M, Mohr LC, Dunbar JB, Grosche B, Hoel DG. Mortality among US commercial pilots and navigators. J Occup Environ Med. 1998 Nov; 40(11):980-5. PMID: 9830605.
      View in: PubMed
    52. Hoel DG, Li P. Threshold models in radiation carcinogenesis. Health Phys. 1998 Sep; 75(3):241-50. PMID: 9721832.
      View in: PubMed
    53. Nietert PJ, Sutherland SE, Silver RM, Pandey JP, Knapp RG, Hoel DG, Dosemeci M. Is occupational organic solvent exposure a risk factor for scleroderma? Arthritis Rheum. 1998 Jun; 41(6):1111-8. PMID: 9627022.
      View in: PubMed
    54. Radivoyevitch T, Hoel DG, Hahnfeldt P, Sachs RK. Size distributions of misrejoining DNA fragments in irradiated cells. Math Biosci. 1998 May; 149(2):107-36. PMID: 9621680.
      View in: PubMed
    55. Radivoyevitch T, Hoel DG, Chen AM, Sachs RK. Misrejoining of double-strand breaks after X irradiation: relating moderate to very high doses by a Markov model. Radiat Res. 1998 Jan; 149(1):59-67. PMID: 9421155.
      View in: PubMed
    56. Radivoyevitch T, Hoel DG, Hahnfeldt PJ, Rydberg B, Sachs RK. Recent data obtained by pulsed-field gel electrophoresis suggest two types of double-strand breaks. Radiat Res. 1998 Jan; 149(1):52-8. PMID: 9421154.
      View in: PubMed
    57. O'Brien ME, Hoel D. Overpowering pain. A serious problem comes out of the closet. Postgrad Med. 1997 Jul; 102(1):198-200, 205-7, 212. PMID: 9224487.
      View in: PubMed
    58. Hoel DG. Ionizing radiation and cancer prevention. Environ Health Perspect. 1995 Nov; 103 Suppl 8:241-3. PMID: 8741791.
      View in: PubMed
    59. Davis DL, Dinse GE, Hoel DG. Decreasing cardiovascular disease and increasing cancer among whites in the United States from 1973 through 1987. Good news and bad news. JAMA. 1994 Feb 09; 271(6):431-7. PMID: 8295317.
      View in: PubMed
    60. Mori H, Nakamura T, Mine M, Kondo H, Okumura Y, Hoel DG. Early mortality rate of atomic bomb survivors based on House Reconstruction Survey. Int J Radiat Biol. 1994 Feb; 65(2):267-75. PMID: 7907124.
      View in: PubMed
    61. Hoel DG, Portier CJ. Nonlinearity of dose-response functions for carcinogenicity. Environ Health Perspect. 1994 Jan; 102 Suppl 1:109-13. PMID: 8187698.
      View in: PubMed
    62. Hoel DG. Questions about radiation and risk estimates that remain after BEIR V. Radiat Res. 1993 Oct; 136(1):137-9. PMID: 8210330.
      View in: PubMed
    63. Davis DL, Bradlow HL, Wolff M, Woodruff T, Hoel DG, Anton-Culver H. Medical hypothesis: xenoestrogens as preventable causes of breast cancer. Environ Health Perspect. 1993 Oct; 101(5):372-7. PMID: 8119245.
      View in: PubMed
    64. Hoel DG, Ron E, Carter R, Mabuchi K. Influence of death certificate errors on cancer mortality trends. J Natl Cancer Inst. 1993 Jul 07; 85(13):1063-8. PMID: 8515493.
      View in: PubMed
    65. Fung VA, Huff J, Weisburger EK, Hoel DG. Predictive strategies for selecting 379 NCI/NTP chemicals evaluated for carcinogenic potential: scientific and public health impact. Fundam Appl Toxicol. 1993 May; 20(4):413-36. PMID: 8314458.
      View in: PubMed
    66. Davis DL, Blair A, Hoel DG. Agricultural exposures and cancer trends in developed countries. Environ Health Perspect. 1993 Apr; 100:39-44. PMID: 8354180.
      View in: PubMed
    67. Portier C, Tritscher A, Kohn M, Sewall C, Clark G, Edler L, Hoel D, Lucier G. Ligand/receptor binding for 2,3,7,8-TCDD: implications for risk assessment. Fundam Appl Toxicol. 1993 Jan; 20(1):48-56. PMID: 8381755.
      View in: PubMed
    68. Davis DL, Hoel DG. Tobacco-associated deaths. Lancet. 1992 Sep 12; 340(8820):666. PMID: 1355221.
      View in: PubMed
    69. Dinse GE, Hoel DG. Exploring time trends in cancer incidence. Cancer Causes Control. 1992 Sep; 3(5):409-17. PMID: 1525321.
      View in: PubMed
    70. Lucier GW, Thompson CL, Hoel DG. Omeprazole, cytochrome P450, and chemical carcinogenesis. Gastroenterology. 1992 May; 102(5):1823-4. PMID: 1314754.
      View in: PubMed
    71. Shimizu Y, Kato H, Schull WJ, Hoel DG. Studies of the mortality of A-bomb survivors. 9. Mortality, 1950-1985: Part 3. Noncancer mortality based on the revised doses (DS86). Radiat Res. 1992 May; 130(2):249-66. PMID: 1574582.
      View in: PubMed
    72. Hoel DG, Davis DL, Miller AB, Sondik EJ, Swerdlow AJ. Trends in cancer mortality in 15 industrialized countries, 1969-1986. J Natl Cancer Inst. 1992 Mar 04; 84(5):313-20. PMID: 1738181.
      View in: PubMed
    73. Piegorsch WW, Carr GJ, Portier CJ, Hoel DG. Concordance of carcinogenic response between rodent species: potency dependence and potential underestimation. Risk Anal. 1992 Mar; 12(1):115-21. PMID: 1574611.
      View in: PubMed
    74. Davis DL, Hoel DG. Figuring out cancer. Int J Health Serv. 1992; 22(3):447-53. PMID: 1644508.
      View in: PubMed
    75. Huff J, Hoel D. Perspective and overview of the concepts and value of hazard identification as the initial phase of risk assessment for cancer and human health. Scand J Work Environ Health. 1992; 18 Suppl 1:83-9. PMID: 1411384.
      View in: PubMed
    76. Swenberg JA, Hoel DG, Magee PN. Mechanistic and statistical insight into the large carcinogenesis bioassays on N-nitrosodiethylamine and N-nitrosodimethylamine. Cancer Res. 1991 Dec 01; 51(23 Pt 2):6409-14. PMID: 1933905.
      View in: PubMed
    77. Hoel DG. A balanced approach to risk assessment. Toxicol Ind Health. 1991 Sep-Nov; 7(5-6):305-11. PMID: 1780871.
      View in: PubMed
    78. de Serres FJ, Hoel DG. Objectives of the collaborative study on the genetic toxicology of 2-amino-N6-hydroxyadenine: an exercise in genetic risk assessment. Mutat Res. 1991 Aug; 253(1):1-3. PMID: 1870606.
      View in: PubMed
    79. Davis DL, Ahlbom A, Hoel D, Percy C. Is brain cancer mortality increasing in industrial countries? Am J Ind Med. 1991; 19(4):421-31. PMID: 2035544.
      View in: PubMed
    80. Hoel DG. Assumptions of the HERP Index. Risk Anal. 1990 Dec; 10(4):623-4; discussion 629-33. PMID: 2287788.
      View in: PubMed
    81. Davis DL, Hoel D, Fox J, Lopez A. International trends in cancer mortality in France, West Germany, Italy, Japan, England and Wales, and the USA. Lancet. 1990 Aug 25; 336(8713):474-81. PMID: 1974997.
      View in: PubMed
    82. Hoel DG, Dinse GE. Using mortality data to estimate radiation effects on breast cancer incidence. Environ Health Perspect. 1990 Jul; 87:123-9. PMID: 2269215.
      View in: PubMed
    83. Portier CJ, Hoel DG, Kaplan NL, Kopp A. Biologically based models for risk assessment. IARC Sci Publ. 1990; (104):20-8. PMID: 2228117.
      View in: PubMed
    84. Davis DL, Hoel D, Percy C, Ahlbom A, Schwartz J. Is brain cancer mortality increasing in industrial countries? Ann N Y Acad Sci. 1990; 609:191-204. PMID: 2264643.
      View in: PubMed
    85. Davis DL, Hoel D. Trends in cancer mortality in industrial countries. Introduction. Ann N Y Acad Sci. 1990; 609:ix-xi. PMID: 2264635.
      View in: PubMed
    86. Davis DL, Hoel D, Fox J, Lopez AD. International trends in cancer mortality in France, West Germany, Italy, Japan, England and Wales, and the United States. Ann N Y Acad Sci. 1990; 609:5-48. PMID: 2264657.
      View in: PubMed
    87. Bailer AJ, Hoel DG. Benzene risk assessments: review and update. Cell Biol Toxicol. 1989 Nov; 5(3):287-95. PMID: 2688843.
      View in: PubMed
    88. Bailer AJ, Hoel DG. Metabolite-based internal doses used in a risk assessment of benzene. Environ Health Perspect. 1989 Jul; 82:177-84. PMID: 2792038.
      View in: PubMed
    89. Hoel DG, Haseman JK, Hogan MD, Huff J, McConnell EE. The impact of toxicity on carcinogenicity studies: implications for risk assessment. Carcinogenesis. 1988 Nov; 9(11):2045-52. PMID: 3052903.
      View in: PubMed
    90. Pedersen LG, Darden TA, Deerfield DW, Anderson MW, Hoel DG. A theoretical study of the effect of methylation or ethylation at O6-guanine in the structure and energy of DNA double strands. Carcinogenesis. 1988 Sep; 9(9):1553-62. PMID: 3409460.
      View in: PubMed
    91. Piegorsch WW, Hoel DG. Exploring relationships between mutagenic and carcinogenic potencies. Mutat Res. 1988 Sep; 196(2):161-75. PMID: 3419441.
      View in: PubMed
    92. Hoel DG. Cancer risk models for ionizing radiation. Environ Health Perspect. 1987 Dec; 76:121-4. PMID: 3447889.
      View in: PubMed
    93. Portier CJ, Hoel DG. Issues concerning the estimation of the TD50. Risk Anal. 1987 Dec; 7(4):437-47. PMID: 3444931.
      View in: PubMed
    94. Hoel DG. Radiation risk estimation models. Environ Health Perspect. 1987 Nov; 75:105-7. PMID: 3319558.
      View in: PubMed
    95. Weinberg CR, Brown KG, Hoel DG. Altitude, radiation, and mortality from cancer and heart disease. Radiat Res. 1987 Nov; 112(2):381-90. PMID: 3685264.
      View in: PubMed
    96. Portier CJ, Hedges JC, Hoel DG. Age-specific models of mortality and tumor onset for historical control animals in the National Toxicology Program's carcinogenicity experiments. Cancer Res. 1986 Sep; 46(9):4372-8. PMID: 3731095.
      View in: PubMed
    97. Brown KG, Hoel DG. Statistical modeling of animal bioassay data with variable dosing regimens: example--vinyl chloride. Risk Anal. 1986 Jun; 6(2):155-66. PMID: 3615985.
      View in: PubMed
    98. Gold LS, Bernstein L, Kaldor J, Backman G, Hoel D. An empirical comparison of methods used to estimate carcinogenic potency in long-term animal bioassays: lifetable vs summary incidence data. Fundam Appl Toxicol. 1986 Feb; 6(2):263-9. PMID: 3699316.
      View in: PubMed
    99. Bernstein L, Gold LS, Ames BN, Pike MC, Hoel DG. Toxicity and carcinogenic potency. Risk Anal. 1985 Dec; 5(4):263-4. PMID: 3843685.
      View in: PubMed
    100. Yanagawa T, Hoel DG. Use of historical controls for animal experiments. Environ Health Perspect. 1985 Nov; 63:217-24. PMID: 4076086.
      View in: PubMed
    101. Hoel DG. Epidemiology and the inference of cancer mechanisms. Natl Cancer Inst Monogr. 1985 May; 67:199-203. PMID: 4047148.
      View in: PubMed
    102. Bernstein L, Gold LS, Ames BN, Pike MC, Hoel DG. Some tautologous aspects of the comparison of carcinogenic potency in rats and mice. Fundam Appl Toxicol. 1985 Feb; 5(1):79-86. PMID: 3987994.
      View in: PubMed
    103. Racine-Poon AH, Hoel DG. Nonparametric estimation of the survival function when cause of death is uncertain. Biometrics. 1984 Dec; 40(4):1151-8. PMID: 6534414.
      View in: PubMed
    104. Portier CJ, Hoel DG. Design of animal carcinogenicity studies for goodness-of-fit of multistage models. Fundam Appl Toxicol. 1984 Dec; 4(6):949-59. PMID: 6519375.
      View in: PubMed
    105. Portier C, Hoel D. Low-dose-rate extrapolation using the multistage model. Biometrics. 1983 Dec; 39(4):897-906. PMID: 6671125.
      View in: PubMed
    106. Brown KG, Hoel DG. Multistage prediction of cancer in serially dosed animals with application to the ED01 study. Fundam Appl Toxicol. 1983 Sep-Oct; 3(5):470-7. PMID: 6642104.
      View in: PubMed
    107. Brown KG, Hoel DG. Modeling time-to-tumor data: analysis of the ED01 study. Fundam Appl Toxicol. 1983 Sep-Oct; 3(5):458-69. PMID: 6642103.
      View in: PubMed
    108. Hoel DG, Wakabayashi T, Pike MC. Secular trends in the distributions of the breast cancer risk factors--menarche, first birth, menopause, and weight--in Hiroshima and Nagasaki, Japan. Am J Epidemiol. 1983 Jul; 118(1):78-89. PMID: 6869366.
      View in: PubMed
    109. Portier C, Hoel D. Optimal design of the chronic animal bioassay. J Toxicol Environ Health. 1983 Jul; 12(1):1-19. PMID: 6631999.
      View in: PubMed
    110. Pike MC, Krailo MD, Henderson BE, Casagrande JT, Hoel DG. 'Hormonal' risk factors, 'breast tissue age' and the age-incidence of breast cancer. Nature. 1983 Jun 30; 303(5920):767-70. PMID: 6866078.
      View in: PubMed
    111. Hoel DG, Kaplan NL, Anderson MW. Implication of nonlinear kinetics on risk estimation in carcinogenesis. Science. 1983 Mar 04; 219(4588):1032-7. PMID: 6823565.
      View in: PubMed
    112. Hoel DG. Carcinogens in the workplace. Science. 1982 Nov 05; 218(4572):560-1. PMID: 17842056.
      View in: PubMed
    113. Kato H, Brown CC, Hoel DG, Schull WJ. Studies of the mortality of A-bomb survivors. Report 7. Mortality, 1950-1978: Part II. Mortality from causes other than cancer and mortality in early entrants. Radiat Res. 1982 Aug; 91(2):243-64. PMID: 7100400.
      View in: PubMed
    114. Hoel DG. Statistical measures of risk. Drug Metab Rev. 1982; 13(5):829-38. PMID: 6754310.
      View in: PubMed
    115. Haseman JK, Hoel DG, Jennrich RI. Some practical problems arising from use of the gamma multihit model for risk estimation. J Toxicol Environ Health. 1981 Sep; 8(3):379-86. PMID: 6808148.
      View in: PubMed
    116. Anderson MW, Hoel DG, Kaplan NL. A general scheme for the incorporation of pharmacokinetics in low-dose risk estimation for chemical carcinogenesis: example--vinyl chloride. Toxicol Appl Pharmacol. 1980 Aug; 55(1):154-61. PMID: 7423500.
      View in: PubMed
    117. Hoel DG. Incorporation of background in dose-response models. Fed Proc. 1980 Jan; 39(1):73-5. PMID: 7351247.
      View in: PubMed
    118. Hoel DG. Animal experimentation and its relevance to man. Environ Health Perspect. 1979 Oct; 32:25-30. PMID: 540597.
      View in: PubMed
    119. Hoel DG. Statistical approaches to toxicological data. Environ Health Perspect. 1979 Oct; 32:267-71. PMID: 540599.
      View in: PubMed
    120. Haseman JK, Hoel DG. Statistical design of toxicity assays: role of genetic structure of test animal population. J Environ Pathol Toxicol. 1979 Jul-Aug; 2(6):1313-27. PMID: 528844.
      View in: PubMed
    121. Hoel DG. Sequential methods in genetic risk assessment. Genetics. 1979 May; 92(1 Pt 1 Suppl):s195-8. PMID: 488701.
      View in: PubMed
    122. Haseman JK, Hoel DG. Statistical design of toxicity assays: role of genetic structure of test animal population. J Toxicol Environ Health. 1979 Jan; 5(1):89-101. PMID: 423309.
      View in: PubMed
    123. Hogan MD, Chi PY, Hoel DG, Mitchell TJ. Association between chloroform levels in finished drinking water supplies and various site-specific cancer mortality rates. J Environ Pathol Toxicol. 1979 Jan-Feb; 2(3):873-87. PMID: 422940.
      View in: PubMed
    124. Guess HA, Hoel DG. The effect of dose on cancer latency period. J Environ Pathol Toxicol. 1977 Nov-Dec; 1(2):279-86. PMID: 553134.
      View in: PubMed
    125. Hoel DG. Biometry branch: summary statement. Environ Health Perspect. 1977 Oct; 20:217-9. PMID: 17539129.
      View in: PubMed
    126. Crump KS, Hoel DG, Langley CH, Peto R. Fundamental carcinogenic processes and their implications for low dose risk assessment. Cancer Res. 1976 Sep; 36(9 pt.1):2973-9. PMID: 975067.
      View in: PubMed
    127. Hoel DG. Occupational carcinogenesis. Statistical extrapolation methods for estimating risks from animal data. Ann N Y Acad Sci. 1976; 271:418-20. PMID: 1069534.
      View in: PubMed
    128. Hoel DG, Gaylor DW, Kirschstein RL, Saffiotti U, Schneiderman MA. Estimation of risks of irreversible, delayed toxicity. J Toxicol Environ Health. 1975 Sep; 1(1):133-51. PMID: 810599.
      View in: PubMed
    129. Hoel DG, Crump KS. Estimating the generation-time distribution of an age-dependent branching process. Biometrics. 1974 Mar; 30(1):125-35. PMID: 4813378.
      View in: PubMed
    130. Hoel DG, Walburg HE. Statistical analysis of survival experiments. J Natl Cancer Inst. 1972 Aug; 49(2):361-72. PMID: 5076821.
      View in: PubMed
    131. Hoel DG. A representation of mortality data by competing risks. Biometrics. 1972 Jun; 28(2):475-88. PMID: 4556703.
      View in: PubMed
    132. Hoel DG, Mitchell TJ. The simulation, fitting, and testing of a stochastic cellular proliferation model. Biometrics. 1971 Mar; 27(1):191-9. PMID: 4926451.
      View in: PubMed
    133. Kenney F, Lee KL, Reel JR, Hoel DG. Regulation of tyrosine alpha-ketoglutarate transaminase in rat liver. IX. Studies of the mechanisms of hormonal inductions in cultured hepatoma cells. J Biol Chem. 1970 Nov 10; 245(21):5806-12. PMID: 4394357.
      View in: PubMed
    Hoel's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _